S Alagna

804 total citations
53 papers, 576 citations indexed

About

S Alagna is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Epidemiology. According to data from OpenAlex, S Alagna has authored 53 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Reproductive Medicine and 6 papers in Epidemiology. Recurrent topics in S Alagna's work include Growth Hormone and Insulin-like Growth Factors (21 papers), Pituitary Gland Disorders and Treatments (12 papers) and Thyroid Disorders and Treatments (7 papers). S Alagna is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (21 papers), Pituitary Gland Disorders and Treatments (12 papers) and Thyroid Disorders and Treatments (7 papers). S Alagna collaborates with scholars based in Italy, United Kingdom and Japan. S Alagna's co-authors include Antonio Masala, Giuseppe Delitala, L Devilla, P. P. Rovasio, G Lotti, Tullio Meloni, S.P.G. Rassu, D. Gallisai, Anna Franca Milia and Maria Laura Cossu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Physiology-Endocrinology and Metabolism and Fertility and Sterility.

In The Last Decade

S Alagna

53 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Alagna Italy 14 260 95 91 80 75 53 576
Flemming Wollesen Denmark 14 278 1.1× 39 0.4× 228 2.5× 132 1.6× 52 0.7× 22 799
P. P. Rovasio Italy 11 118 0.5× 85 0.9× 57 0.6× 30 0.4× 44 0.6× 27 289
N Shimizu Japan 17 347 1.3× 39 0.4× 102 1.1× 31 0.4× 38 0.5× 69 772
B. J. Ormston United Kingdom 11 857 3.3× 30 0.3× 77 0.8× 114 1.4× 47 0.6× 14 1.1k
H. G. Doerr Germany 15 227 0.9× 77 0.8× 48 0.5× 34 0.4× 106 1.4× 29 652
Hans Yde Denmark 14 371 1.4× 19 0.2× 134 1.5× 43 0.5× 30 0.4× 21 796
P. T. Pullan Australia 13 377 1.4× 46 0.5× 188 2.1× 31 0.4× 55 0.7× 30 774
Véronique Raverot France 15 452 1.7× 45 0.5× 137 1.5× 56 0.7× 74 1.0× 64 744
Ediz Yeşilkaya Türkiye 15 183 0.7× 24 0.3× 88 1.0× 178 2.2× 140 1.9× 40 710
D Bisbocci Italy 10 115 0.4× 12 0.1× 43 0.5× 50 0.6× 27 0.4× 31 422

Countries citing papers authored by S Alagna

Since Specialization
Citations

This map shows the geographic impact of S Alagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Alagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Alagna more than expected).

Fields of papers citing papers by S Alagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Alagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Alagna. The network helps show where S Alagna may publish in the future.

Co-authorship network of co-authors of S Alagna

This figure shows the co-authorship network connecting the top 25 collaborators of S Alagna. A scholar is included among the top collaborators of S Alagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Alagna. S Alagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faedda, Rossana, et al.. (2008). Hormonal Strategies for Fertility Preservation in Patients Receiving Cyclophosphamide to Treat Glomerulonephritis: A Nonrandomized Trial and Review of the Literature. American Journal of Kidney Diseases. 52(5). 887–896. 19 indexed citations
2.
Cossu, Maria Laura, et al.. (2007). Emergency Surgical Conditions after Biliopancreatic Diversion. Obesity Surgery. 17(5). 637–641. 11 indexed citations
3.
Alagna, S, et al.. (2006). Biliopancreatic diversion: long-term effects on gonadal function in severely obese men. Surgery for Obesity and Related Diseases. 2(2). 82–86. 29 indexed citations
4.
Cossu, Maria Laura, Giovanni Battista Meloni, Stefano Profili, et al.. (2004). Impact of Age on Long-Term Complications after Biliopancreatic Diversion. Obesity Surgery. 14(9). 1182–1186. 11 indexed citations
5.
Alagna, S, Maria Laura Cossu, Antonio Masala, et al.. (2003). Evaluation of serum leptin levels and thyroid function in morbidly obese patients treated with bariatric surgery. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 8(2). 95–99. 15 indexed citations
6.
Masala, Antonio, Marcello Atzeni, S Alagna, et al.. (2003). Growth hormone secretion in polytransfused prepubertal patients with homozygous β-thalassemia. Effect of longterm recombinant GH (recGH) therapy. Journal of Endocrinological Investigation. 26(7). 623–628. 10 indexed citations
7.
Sartório, Alessandro, Gian Marco Conte, Antonio Conti, et al.. (2000). Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major. Journal of Endocrinological Investigation. 23(6). 356–361. 13 indexed citations
8.
Alagna, S, Antonio Masala, D. Gallisai, et al.. (1992). Parathyroid function and bone metabolism in children with beta thalassaemia major: effects of sex steroid treatment.. PubMed. 1(3). 153–7. 4 indexed citations
9.
Moro, Mirella, Antonio Masala, Paola Maria Toja, et al.. (1991). Chronic treatment with Parlodel LAR® of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas. European Journal of Endocrinology. 125(5). 494–501. 11 indexed citations
10.
11.
Alagna, S, et al.. (1985). Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy. Journal of Endocrinological Investigation. 8(1). 25–29. 2 indexed citations
12.
Dessı̀-Fulgheri, Paolo, S Alagna, P. Madeddu, et al.. (1985). Blunted adrenocorticotrophic hormone release during captopril treatment.. PubMed. 3(2). S125–7. 2 indexed citations
13.
Masala, Antonio, et al.. (1982). Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients. Journal of Endocrinological Investigation. 5(1). 39–41. 4 indexed citations
14.
Masala, Antonio, et al.. (1980). Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in children receiving phenobarbitone.. BMJ. 281(6249). 1175–1177. 13 indexed citations
15.
Masala, Antonio, et al.. (1979). Effect of synthetic LH-RH and hCG administration on plasma testosterone, androstenedione, and estradiol 17beta levels in normal men and in patients with idiopathic oligospermia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(1). 71–3. 4 indexed citations
16.
Masala, Antonio, et al.. (1978). INHIBITION OF LACTATION AND INHIBITION OF PROLACTIN RELEASE AFTER MECHANICAL BREAST STIMULATION IN PUERPERAL WOMEN GIVEN TAMOXIFEN OR PLACEBO. BJOG An International Journal of Obstetrics & Gynaecology. 85(2). 134–137. 18 indexed citations
17.
Delitala, Giuseppe, S Alagna, & Antonio Masala. (1977). [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 81(6). 547–54. 1 indexed citations
18.
Delitala, Giuseppe, et al.. (1977). Inhibition of prolactin release by metergoline administration in man.. PubMed. 27(1). 31–3. 13 indexed citations
19.
Delitala, Giuseppe, Antonio Masala, S Alagna, L Devilla, & G Lotti. (1977). Metergoline in the inhibition of puerperal lactation.. BMJ. 1(6063). 744–746. 11 indexed citations
20.
Delitala, Giuseppe, Antonio Masala, & S Alagna. (1977). Suppression of pimozide-induced prolactin secretion by piridoxine (vitamin B6).. PubMed. 27(5). 191–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Flemming Wollesen Breakdown of academic impact, for papers by P. P. Rovasio Breakdown of academic impact, for papers by N Shimizu Breakdown of academic impact, for papers by B. J. Ormston Breakdown of academic impact, for papers by H. G. Doerr Breakdown of academic impact, for papers by Hans Yde Breakdown of academic impact, for papers by P. T. Pullan Breakdown of academic impact, for papers by Véronique Raverot Breakdown of academic impact, for papers by Ediz Yeşilkaya Breakdown of academic impact, for papers by D Bisbocci
Rankless by CCL
2026